Download presentation
Presentation is loading. Please wait.
Published byZalán Kiss Modified over 5 years ago
1
Guselkumab for the treatment of severe refractory psoriasis in a pediatric patient
Sa Rang Kim, BSc, Nour Kibbi, MD, Brittany G. Craiglow, MD JAAD Case Reports Volume 5, Issue 6, Pages (June 2019) DOI: /j.jdcr Copyright © 2019 American Academy of Dermatology, Inc. Terms and Conditions
2
Fig 1 Response to guselkumab. A, Back with sharply demarcated pink-red scaly plaques, which were persistent despite treatment with methotrexate, adalimumab, and ustekinumab. B, Back with postinflammatory hyperpigmentation. There has been near complete resolution of psoriasis after 5 months of treatment with guselkumab. JAAD Case Reports 2019 5, DOI: ( /j.jdcr ) Copyright © 2019 American Academy of Dermatology, Inc. Terms and Conditions
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.